Searched for
NEULAND PHARMA
Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Q4 earnings roundup: Raymond Realty, MCX among 19 companies that delivered 100%+ growth in sales and PATA select group of 19 large-cap BSE-listed companies achieved triple-digit growth in both profit and revenue during Q4FY26, indicating stron...
- Geopolitical tensions keep markets nervous despite strong earnings: Dipan MehtaGeopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...
- Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4Neuland Laboratories shares saw a significant jump following a strong Q4 performance. The company reported a massive increase in profit and...
- Earnings season is strong, but Q1 pain is coming: Dipan MehtaMarket expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to pote...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Pharma stocks catch a cold as US softens stance on Biosecure ActShares of Syngene International dropped 5.7%, Piramal Pharma fell 4.2%, Lauras Labs and Neuland Laboratories declined 3% and Divi's Laborat...
- Sensex falls! But these stocks gained over 10% on BSEIn the Nifty 50 index, 7 stocks ended in the green, while 43 stocks closed in the red in today's trade.
- Sensex rises! These stocks are up over 15% on BSEIn the Nifty50 index, 28 stocks were trading in the green, while 22 stocks were in the red.
- Aurobindo Pharma among 8 BSE Pharma Index stocks which surge to new 52-week highs on FridayGlenmark Life Sciences achieved a new 52-week high at Rs. 658 on July 21, 2023. As a subsidiary of Glenmark Pharma, Glenmark Life Sciences ...
- This stock surged 650% last year, and drew marquee investors like Dolly Khanna in Q4Apart from Dolly Khanna, Mukul Agrawal, another renowned value investor, increased his holding in the company to 2.34 per cent from 1.95 pe...
- Buy Neuland Laboratories, target Rs 1000: HDFC SecuritiesBuy Neuland Laboratories Ltd. at a price target of Rs 1000..
- Evolvence India Fund to exit Neuland Labs; puts entire stake of 33 per cent on saleVishy Chebrol, one of the founders and managing directors of InvAscent, confirmed the fund is looking at exiting its investment in the comp...
- Neuland Labs to focus on contract researchHyderabad-based mid-sized pharma player Neuland Labs has raised $30 million for capital expenditure on contract research facilities and its...
Load More
